Sheng-li Liu, Lu-wei Zhang, Jun Tian*. Pseudohyperkalemia with Myelofibrosis after Splenectomy[J].Chinese Medical Sciences Journal, 2016, 31(4): 258-260.
Weisberg LS. Management of severe hyperkalemia. Crit Care Med 2008; 36: 3246-51.
2
Sevastos N, Theodossiades G, Savvas SP, et al. Pseudohy- perkalemia in patients with increased cellular components of blood. Am J Med Sci 2006; 331: 17-21.
3
Sevastos N, Theodossiades G, Archimandritis AJ. Pseudo- hyperkalemia in serum: a new insight into an old pheno- menon. Clin Med Res 2008; 6: 30-32.
4
Ong Y L, Deore R, Elagnaf M. Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead to inappropriate management of patients. Int J Lab Hematol 2010; 32: e151-7.
5
Mesa RA, Hanson CA, Rajkumar SV, et al. Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood 2000; 96:3374-80.
6
Tefferi A. Myelofibrosis with Myeloid Metaplasia. New Engl J Med 2000; 342:1255-65.
7
Garwicz D, Karlman M. Early recognition of reverse pseudohyperkalemia in heparin plasma samples during leukemic hyperleukocytosis can prevent iatrogenic hypo- kalemia. Clin Biochem 2012; 45:1700-2.
8
Ruddy KJ, Wu D, Brown JR. Pseudohyperkalemia in chronic lymphocytic leukemia. J Clin Oncol 2008; 26: 2781-2.
9
Kellerman PS, Thornbery JM. Pseudohyperkalemia due to pneumatic tube transport in a leukemic patient. Am J Kidney Dis 2005; 46:746-8.